Translation News and Research

RSS

Bruker first quarter revenue increases 29% to $357.0 million

Bruker Corporation today reported financial results for the first quarter ended March 31, 2011.

28 Apr 2011

Invacare first quarter earnings per share increases 156% to $0.23

Invacare Corporation today announced its financial results for the quarter ended March 31, 2011.

28 Apr 2011

Thermo Fisher revenues increase 4% to $2.72 billion for first quarter 2011

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.

From Thermo Fisher Scientific Inc. 27 Apr 2011

Waters first quarter sales rise 16% to $428 million

Waters Corporation reported first quarter 2011 sales of $428 million, an increase of 16%, from sales of $368 million in the first quarter of 2010. In the quarter, foreign currency translation added 2% to sales growth.

26 Apr 2011

OCM announces acquisition of Diagnostics Plus

One Call Medical, the nation's leading provider of specialty services to insurance payers, today announced its acquisition of Diagnostics Plus, a provider network for advanced radiology and electrodiagnostic services, including MRIs, CT scans, and electromyography.

25 Apr 2011

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

More than 1,800 Chinese oncology professionals attended the NCCN 4th Annual Asia Scientific Congress in Shanghai, China, on April 9, 2011, which featured expert faculty from NCCN Member Institutions and thought leaders in cancer care from major Chinese cancer centers.

25 Apr 2011

New trial in UK to test whether statins could be used to treat pre-eclampsia

Pregnant women could benefit from a pioneering trial that will test whether heart disease drugs can be used to treat pre-eclampsia.

21 Apr 2011

U.S. DOD awards $4.5M to NYU Langone Medical Center for novel breast cancer research

NYU Langone Medical Center announced today the U.S. Department of Defense Breast Cancer Research Program of the Office of the Congressionally Directed Medical Research Programs has awarded Silvia Formenti, MD, the Sandra and Edward Meyer Professor and Chair of the Department of Radiation Oncology a $4.5 million Multi-Team Award to conduct novel breast cancer research.

21 Apr 2011

St. Jude Medical first quarter net sales increases 9% to $1.376 billion

St. Jude Medical, Inc. today reported sales and net earnings for the first quarter ended April 2, 2011.

20 Apr 2011

Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology.

From Precision NanoSystems Inc. 20 Apr 2011

Springer to publish new journal of Society of Behavioral Medicine

Starting in 2011, Springer will publish Translational Behavioral Medicine: Practice, Policy, Research (TBM), a journal of the Society of Behavioral Medicine. The journal will debut with a special section, "Information Technology and Evidence Implementation."

20 Apr 2011

Tissue Genesis commences PVD clinical trials with adipose-derived adult stem cell-coated vascular grafts

Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.

20 Apr 2011

Biomet net sales increase 1% to $678 million for third fiscal quarter 2011

Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2011.

12 Apr 2011

Lecture to explain science behind modern pharmaceutical products

The science behind the creation of medicines is the subject of a lecture at the University of Greenwich's Medway Campus on Wednesday, April 13.

8 Apr 2011

Celldex presents CDX-1127 preclinical data against cancer at AACR meeting

Celldex Therapeutics, Inc. today announced that new data on its preclinical therapeutic antibody program, CDX-1127, is being presented in a poster presentation at the 2011 American Association for Cancer Research 102nd Annual Meeting in Orlando, FL.

6 Apr 2011

UC researchers sequence individual glioblastoma genomes and track abnormalities through the bloodstream

Medical scientists know this about glioblastoma multiforme: the malignant brain tumor is aggressive, it is elusive, and it appears in different permutations.

5 Apr 2011

Global Autism Alliance launches new Internet website for public

In celebration of World Autism Day, April 2, the Global Autism Alliance will launch its Internet website, www.GlobalAutismAlliance.com, and premiere a video co-produced by representatives from around the world.

2 Apr 2011

NUS, Agilent partner for lipidomics research

Agilent Technologies Inc. and the National University of Singapore today announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states.

30 Mar 2011

VisualSonics introduces Vevo LAZR system to advance cancer research

VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., today announced the launch of the Vevo LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market.

25 Mar 2011

New insights into multiple myeloma research

Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights into the events that lead to this form of cancer and could influence the direction of multiple myeloma research.

24 Mar 2011